Growth Metrics

Jaguar Health (JAGX) Net Cash Flow (2016 - 2025)

Jaguar Health (JAGX) has disclosed Net Cash Flow for 11 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 182.81% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3000.0 through Dec 2025, down 100.19% year-over-year, with the annual reading at -$57000.0 for FY2025, 103.59% down from the prior year.
  • Net Cash Flow for Q4 2025 was $4.3 million at Jaguar Health, up from $1.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $24.2 million in Q1 2021, with the low at -$19.5 million in Q3 2021.
  • Average Net Cash Flow over 5 years is $60600.0, with a median of $61500.0 recorded in 2021.
  • The sharpest move saw Net Cash Flow tumbled 2071.99% in 2022, then skyrocketed 1848.57% in 2023.
  • Over 5 years, Net Cash Flow stood at $4.7 million in 2021, then tumbled by 210.05% to -$5.1 million in 2022, then soared by 162.16% to $3.2 million in 2023, then crashed by 262.89% to -$5.2 million in 2024, then surged by 182.81% to $4.3 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $4.3 million, $1.6 million, and -$3.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.